Literature DB >> 21597991

Effects of acute ethanol on corticotropin-releasing hormone and β-endorphin systems at the level of the rat central amygdala.

Minh P Lam1, Christina Gianoulakis.   

Abstract

RATIONALE: The endogenous opioid and corticotropin-releasing hormone (CRH) systems, present in the central amygdala (CeA), are implicated in alcohol consumption.
OBJECTIVES: The purpose of this study is to investigate the hypothesis that, in CeA, alcohol stimulates CRH release, which then stimulates β-endorphin release.
MATERIALS AND METHODS: Rats were unilaterally implanted with a guide cannula to aim microdialysis probes in CeA. Experiment 1: rats received an intraperitoneal (IP) injection of various ethanol doses (0.0, 2.0, 2.4, or 2.8 g ethanol/kg body weight) and microdialysates were sampled at 30-min intervals to determine the effects over time of acute alcohol on the extracellular CRH concentrations in CeA. Experiment 2: phosphate-buffered saline, CRH, or CRH receptor (CRHR) antagonists (antalarmin or anti-sauvagine-30) was microinjected into CeA followed by a saline or 2.8 g/kg ethanol IP injection to determine the effects of CRHR activation or blockade in CeA on the basal and alcohol-stimulated release of β-endorphin. CRH and β-endorphin dialysate contents were determined using specific radioimmunoassays.
RESULTS: Acute alcohol induced a delayed increase in the extracellular CRH levels in CeA. Behavioural data showed no difference in locomotion between alcohol- and saline-treated rats. However, a transient increase in grooming was observed which did not correspond with alcohol-induced changes in CRH. Local CRH microinjections increased the extracellular β-endorphin concentrations in CeA. CRHR1 and CRHR2 blockade with microinjections of antalarmin and anti-sauvagine-30, respectively, attenuated the alcohol-induced increase of extracellular β-endorphin in CeA.
CONCLUSIONS: Acute alcohol exerts indirect actions on CRH release and induced interactions of the CRH and β-endorphin systems in CeA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21597991     DOI: 10.1007/s00213-011-2337-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  44 in total

Review 1.  Microdialysis measurement of in vivo neuropeptide release.

Authors:  K M Kendrick
Journal:  J Neurosci Methods       Date:  1990-09       Impact factor: 2.390

2.  C fragment of lipotropin has a high affinity for brain opiate receptors.

Authors:  N J Birdsall; E C Hulme
Journal:  Nature       Date:  1976-04-29       Impact factor: 49.962

3.  Dynorphin-(1-13), an extraordinarily potent opioid peptide.

Authors:  A Goldstein; S Tachibana; L I Lowney; M Hunkapiller; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

4.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

5.  Inbred strains of mice with variable sensitivity to ethanol exhibit differences in the content and processing of beta-endorphin.

Authors:  C Gianoulakis; A Gupta
Journal:  Life Sci       Date:  1986-12-15       Impact factor: 5.037

6.  The role of amino-terminal sequence of beta-endorphin and dynorphin in the determination of opiate receptor type selectivity.

Authors:  J K Chang; K J Chang
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

7.  Pharmacological characterization of opioid receptors influencing the secretion of corticotrophin releasing factor in the rat.

Authors:  J C Buckingham; T A Cooper
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

8.  Microdialysis of extracellular endogenous opioid peptides from rat brain in vivo.

Authors:  N T Maidment; D R Brumbaugh; V D Rudolph; E Erdelyi; C J Evans
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

9.  Central administration of an opiate antagonist decreases oral ethanol self-administration in rats.

Authors:  C J Heyser; A J Roberts; G Schulteis; G F Koob
Journal:  Alcohol Clin Exp Res       Date:  1999-09       Impact factor: 3.455

10.  Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study.

Authors:  Minh P Lam; Peter W Marinelli; Li Bai; Christina Gianoulakis
Journal:  Psychopharmacology (Berl)       Date:  2008-08-08       Impact factor: 4.530

View more
  17 in total

Review 1.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

2.  Insights into the Neurobiology of Anxiety and a Potential Target for Pharmacotherapy.

Authors:  Rami Hamati
Journal:  J Neurosci       Date:  2018-10-17       Impact factor: 6.167

3.  Decreased immunoreactivity of the polypeptide precursor pro-opiomelanocortin (POMC) and the prohormone convertase pc1/3 after chronic ethanol exposure in Sprague-Dawley rats.

Authors:  Montserrat Navarro; Inmaculada Cubero; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2012-10-10       Impact factor: 3.455

Review 4.  Driving the Downward Spiral: Alcohol-Induced Dysregulation of Extended Amygdala Circuits and Negative Affect.

Authors:  Samuel W Centanni; Gaurav Bedse; Sachin Patel; Danny G Winder
Journal:  Alcohol Clin Exp Res       Date:  2019-08-30       Impact factor: 3.455

5.  Reduction of ethanol intake by corticotropin-releasing factor receptor-1 antagonist in "heavy-drinking" mice in a free-choice paradigm.

Authors:  Diego Correia; Bruno Jacson Martynhak; Marcela Pereira; Isadora Pozzetti Siba; Andrea Frozino Ribeiro; Rosana Camarini; Roseli Boerngen-Lacerda
Journal:  Psychopharmacology (Berl)       Date:  2015-03-24       Impact factor: 4.530

Review 6.  Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking.

Authors:  Allyson L Schreiber; Nicholas W Gilpin
Journal:  Handb Exp Pharmacol       Date:  2018

7.  Amygdalar neuronal plasticity and the interactions of alcohol, sex, and stress.

Authors:  T A Retson; J B Hoek; R C Sterling; E J Van Bockstaele
Journal:  Brain Struct Funct       Date:  2014-08-01       Impact factor: 3.270

8.  Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety.

Authors:  Beverly A S Reyes; J L Kravets; K L Connelly; E M Unterwald; E J Van Bockstaele
Journal:  Brain Struct Funct       Date:  2016-07-04       Impact factor: 3.270

9.  Direct targeting of peptidergic amygdalar neurons by noradrenergic afferents: linking stress-integrative circuitry.

Authors:  J L Kravets; B A S Reyes; E M Unterwald; E J Van Bockstaele
Journal:  Brain Struct Funct       Date:  2013-11-23       Impact factor: 3.270

10.  The ethanol metabolite acetic acid activates mouse nucleus accumbens shell medium spiny neurons.

Authors:  Andrew D Chapp; Paul G Mermelstein; Mark J Thomas
Journal:  J Neurophysiol       Date:  2021-01-06       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.